Cyclosporine attenuates the adenylyl cyclase superactivation induced by chronic cannabinoid treatment

Banafshe, 2005, The effect of cyclosporine on the development and expression of cannabinoid tolerance in mice, Pharmacol. Biochem. Behav., 82, 658, 10.1016/j.pbb.2005.11.006 Dill, 1988, Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs, J. Pharmacol. Exp. Ther., 244, 1157 Ding, 2004, Raf kinase activation of adenylyl cyclases: isoform-selective regulation, Mol. Pharmacol., 66, 921, 10.1124/mol.66.4.921 Ejtemaei Mehr, 2003, Inhibition by immunophilin ligands of morphine-induced tolerance and dependence in guinea pig ileum, Eur. J. Pharmcol., 467, 205, 10.1016/S0014-2999(03)01632-7 Gary-Gouy, 2006, Cyclosporin-A inhibits ERK phosphorylation in B cells by modulating the binding of Raf protein to Bcl2, Biochem. Biophys. Res. Commun., 344, 134, 10.1016/j.bbrc.2006.03.121 Groblewski, 1994, Cyclosporin A inhibits Ca2+/calmodulin-dependent protein phosphatase and secretion in pancreatic acinar cells, J. Biol. Chem., 269, 15111 Handschumacher, 1984, Cyclophilin: a specific cytosolic binding protein for cyclosporin A, Science, 226, 544, 10.1126/science.6238408 Homayoun, 2002, The effect of cyclosporin A on morphine tolerance and dependence: involvement of nitric oxide pathway, Eur. J. Pharmacol., 452, 67, 10.1016/S0014-2999(02)02243-4 Howlett, 1995, Pharmacology of cannabinoid receptors, Annu. Rev. pharmacol. Toxicol., 35, 607, 10.1146/annurev.pa.35.040195.003135 Mackie, 1995, Cannabinoid activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in atT20 cells transfected with rat brain cannabinoid receptor, J. Neurosci., 15, 6552, 10.1523/JNEUROSCI.15-10-06552.1995 Matsuda, 1990, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature, 346, 561, 10.1038/346561a0 Munro, 1993, Molecular characterization of peripheral receptor for cannabinoids, Nature, 365, 61, 10.1038/365061a0 Rhee, 2000, Differential superactivation of adenylyl cyclase isozymes after chronic activation of the CB1 cannabinoid receptor, Mol. Pharmacol., 57, 746, 10.1124/mol.57.4.746 Rubino, 2000, Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions, Neuropharmacology, 39, 1331, 10.1016/S0028-3908(99)00196-3 Shapira, 2003, Long term interaction between opioid and cannabinoid agonists at the cellular level: cross-desensitization and down regulation, Brain Res., 960, 190, 10.1016/S0006-8993(02)03842-8 Steiner, 1992, High brain densities of immunophilin FKBP colocalized with calcineurin, Nature, 358, 584, 10.1038/358584a0 Synder, 1998, Neural action of immunophilin ligands, Trends Pharmacol. Sci., 19, 21, 10.1016/S0165-6147(97)01146-2 Tan, 2001, Tyrosine kinase-mediated serine phosphorylation of adenylyl cyclase, Biochemistry, 40, 1702, 10.1021/bi0015818 Varga, 2003, Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic delta-opioid agonist treatment, J. Pharmacol. Exp. Ther., 306, 109, 10.1124/jpet.103.049643 Walker, 1989, Cyclosporin A inhibits protein kinase C activity: a contributing mechanism in the development of nephrotoxicity, Biochem. Biophys. Res. Commun., 160, 409, 10.1016/0006-291X(89)91671-9 Yue, 2006, Chronic morphine-mediated adenylyl cyclase superactivation is attenuated by the Raf-1 inhibitor, GW5074, Eur. J. Pharmacol., 540, 57, 10.1016/j.ejphar.2006.04.033